HealthDay: 'Neuroprotectant' drug could boost outcomes after stroke
UC's Broderick comments on study
A new study found using a "neuroprotectant" drug alongside the standard surgical removal of a blood clot may reduce the risk of death and disability following a stroke.
Researchers presenting data at the International Stroke Conference reported the medication, called ApTOLL, protects brain tissue from continuing damage by cooling down inflammation.
More than 150 people who had an ischemic stroke were enrolled in the study in France and Spain, either receiving ApTOLL at two different doses or a placebo medication in addition to mechanical blood clot removal.
The patients who received the higher dose of ApTOLL were four times less likely to die from stroke compared to the patients who received a placebo.
Joseph Broderick, MD, professor in UC’s Department of Neurology and Rehabilitation Medicine in the College of Medicine, director of the UC Gardner Neuroscience Institute and a UC Health physician, commented on the study for HealthDay. He said the drug needs to be tested more thoroughly before becoming a standard of care.
"The data warrants further study in a phase 3 study, but differences seen in this trial may be due to small number of patients and imbalances in factors related to outcome," Broderick said, adding that a much larger trial would be needed to confirm the findings.
Featured photo at top of Dr. Broderick. Photo/Joseph Fuqua II/University of Cincinnati
Related Stories
Colorado silica dust trial could change the way industry does business
May 17, 2026
Betsy Malloy, Andrew Katsanis Professor of Law, at the University of Cincinnati, spoke with Bloomberg Law about how a Colorado trial could change the way the stone fabrication industry does business.
Driven by curiosity, guided by care
May 14, 2026
Max Wilson, a University of Cincinnati College of Allied Health Sciences health sciences major on the pre-physician assistant track, found his path expanding beyond the classroom and into hands-on research focused on human performance and patient care.
New cohort of nursing students get ready to join co-ops
May 14, 2026
A new chapter is beginning for more than 100 University of Cincinnati College of Nursing rising seniors as they embark on one of the most distinctive experiences in undergraduate nursing education: the UC Nursing Co-op Program. The incoming cohort will fan out across Cincinnati's premier healthcare institutions, stepping into some of the most dynamic and specialized clinical environments in the region. Placement sites include UC Medical Center (UCMC), West Chester Hospital, Cincinnati Children's Hospital Medical Center (CCHMC) Burnet, College Hill, and Liberty campus.